#genetictesting

Cut yearly PSA tests and discover how a simple genetic panel can save thousands while protecting your health. Learn the true cost of screening and smarter alter

GeneDx’s lead in genetic testing is challenged by fierce competition and price cuts, putting its market power and pricing at risk.

Tom Steyer’s $100M bet on Natera highlights high-conviction interest in genetic testing’s growth and signals a potential breakout for the stock.